ARCHIVES

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001